跳至主要内容
临床试验/NCT01938326
NCT01938326已完成不适用

Postoperative Pain and Quality of Life After Single-incision Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy for Early Gastric Cancer - a Randomized Controlled Trial

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86
试验地点
1
主要终点
Maximum pain score using VAS at postoperative day#1

研究概览

简要总结

  1. Compare the immune response and postoperative complications between pure SIDG (single-incision laparoscopic distal gastrectomy) and TLDG (totally laparoscopic distal gastrectomy) for early gastric cancer (EGC)
  2. Validate the safety, usefulness, minimal invasiveness and feasibility of SIDG (EGC)

详细描述

There are some trends of reducing the numbers and lengths of wounds in the fields of laparoscopic surgery.

Recently, Beyond laparoscopy-assisted distal gastrectomy (LADG), which has the mini-laparotomy, TLDG, which has no mini-laparotomy in epigastrium but in umbilicus, has been popular procedure in the treatment of gastric cancer. Furthermore, the report on early experience of SIDG, which has no incision except umbilicus port, is going to be published.

However, there've been no objective reports and data on real minimal invasiveness and benefits between 2 procedures. In this study, I would like to find out the benefits of the reducing port and wound size by comparing the above 2 procedures' immune response and postoperative complications.

This study is planned as a phase II study.

There are no references on this subject, so the investigators set the numbers of each groups into 30, which is minimal requirement for the parametric comparisons.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinically early gastric cancer, potentially possible to perform distal gastrectomy (cancer in the distal 2/3rds)
  • 20< Age < 80
  • Exclusion Criteria
  • history of other malignancy
  • received preoperative chemotherapy

排除标准

  • 未提供

结局指标

主要结局

Maximum pain score using VAS at postoperative day#1

时间窗: Postoperative day 1

Maximum postoperative pain using the visual analogue scale

次要结局

  • Hospital stay(Days until discharge)
  • Maximum pain scores using VAS(From postoperative day 0 to 5)
  • Operation time(Time during operation)
  • Early postoperative complication(within 30 days from the operation)
  • Time to first flatus(Days until first flatus)
  • Estimated blood loss(During operation)
  • Time to first soft fluid diet(Days until first soft fluid diet)
  • EORTC-C30 and STO22(Preoperative, 2 weeks after surgery, 1 month after surgery, 6 months after surgery, 12 months after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sang-Hoon Ahn

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验